Trials / Completed
CompletedNCT01539304
Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis: Double Blinded, Randomized, Placebo Controlled, Parallel Designed, Multi-centered, Phase III Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 245 (actual)
- Sponsor
- SamA Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 24 Months – 15 Years
- Healthy volunteers
- Not accepted
Summary
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "CITUS Dry Syrup" in Children With Perennial Allergic Rhinitis: Double Blinded, Randomized, Placebo Controlled, Parallel Designed, Multi-centered, Phase III Study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CITUS Dry Syrup | Pranlukast 10% dry syrup, b.i.d. |
| DRUG | Placebo | Placebo dry syrup, b.i.d |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-08-01
- Completion
- 2011-09-01
- First posted
- 2012-02-27
- Last updated
- 2012-02-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01539304. Inclusion in this directory is not an endorsement.